IGF2BP1 and pancreatic neuroendocrine tumor: To further investigate this hypothesis, we analyzed IGF2BP1 expression in insulinomas of 10–15 weeks old RIP1-Tag2 (RT) mice, a well-characterized pancreatic neuroendocrine tumor mouse model of ß-cell carcinogenesis [34].